A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Lamivudine

DRUG

Stavudine

DRUG

Zidovudine

DRUG

Didanosine

Trial Locations (13)

19104

Univ of Pennsylvania / Infectious Diseases Division, Philadelphia

20037

Anderson Clinical Research, Washington D.C.

George Washington Med Ctr / Clinical Trials Unit, Washington D.C.

27599

Univ of North Carolina / Infectious Disease Division, Chapel Hill

28207

The Nalle Clinic / Clinical Research Dept, Charlotte

60610

Chicago Ctr for Clinical Research, Chicago

60611

Northwestern Univ, Chicago

68195

Univ of Nebraska, Omaha

75225

Southwest Infectious Disease Association / PA, Dallas

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

90509

Harbor UCLA Med Ctr / Division of Immunology / N-24, Torrance

94705

East Bay AIDS Clinic, Berkeley

00731

Hosp Regional de Ponce - Area Vieja, Ponce

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00002168 - A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients | Biotech Hunter | Biotech Hunter